Skip to main content
SpringerLink
Log in

CGS 26529: The biological profile of a novel, orally active 5-lipoxygenase inhibitor with an extended duration of action

  • II. Lipid mediators
  • Published:
Inflammation Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Samuelsson B. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 1983;220:568–75.

    PubMed  Google Scholar 

  2. Carter GW, Young PR, Albert DH, Bouska J, Dyer R, Bell RL, et al. 5-Lipoxygenase inhibitory activity of zileuton. J Pharmacol Exp Ther 1991;256:929–37.

    PubMed  Google Scholar 

  3. Ku EC, Raychaudhuri A, Ghai G, Kimble EF, Lee WH, Colombo C, et al. Characterization of CGS 8515 as a selective 5-lipoxygenase inhibitor using in vitro and in vivo models. Biochim Biophys Acta 1988;959:332–42.

    PubMed  Google Scholar 

  4. Sweeny FJ, Eskra JD, Carty TJ. Development of a system for evaluating 5-lipoxygenase inhibitors using human whole blood. Prost Leukotrienes Med 1987;28:73–93.

    Google Scholar 

  5. Kimble E, Kowalski T, White D, Raychaudhuri A, Pastor G, Chertock H, et al. CGS 22745: a selective orally active inhibitor of 5-lipoxygenase. Agents Actions 1991;34:125–8.

    PubMed  Google Scholar 

  6. Almeida AP, Bayer BM, Horakova Z, Beaven MA. Influence of indomethacin and other anti-inflammatory drugs on mobilization and production of neutrophils: studies with carrageenaninduced inflammation in rats. J Pharmacol Exp Ther 1980;214:74–9.

    PubMed  Google Scholar 

  7. Tsunoda H, Abe S, Sakuma Y, Katayama S, Katayama K. Involvement of leukotriene C4 in PAF-induced death in mice. Prost. Leukotrienes and Essential Fatty Acids 1990;39:291–4.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Research Department, Pharmaceuticals Division, Ciba-Geigy Corp., 556 Morris Ave., 07901, Summit, NJ, USA

    E. Kimble, T. Kowalski, P. Peters, W. Lee, J. Koehler, A. Raychaudhuri, H. Chertock, V. Blancuzzi & J. van Duzer

Authors
  1. E. Kimble
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Kowalski
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Peters
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. W. Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. Koehler
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Raychaudhuri
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. H. Chertock
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. V. Blancuzzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. J. van Duzer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kimble, E., Kowalski, T., Peters, P. et al. CGS 26529: The biological profile of a novel, orally active 5-lipoxygenase inhibitor with an extended duration of action. Inflamm Res 44 (Suppl 2), S147–S148 (1995). https://doi.org/10.1007/BF01778305

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01778305

Keywords

Search

Navigation